Yemisi Solanke

624 total citations
16 papers, 472 citations indexed

About

Yemisi Solanke is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Yemisi Solanke has authored 16 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Genetics. Recurrent topics in Yemisi Solanke's work include Inflammatory Bowel Disease (5 papers), Phosphodiesterase function and regulation (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Yemisi Solanke is often cited by papers focused on Inflammatory Bowel Disease (5 papers), Phosphodiesterase function and regulation (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Yemisi Solanke collaborates with scholars based in United Kingdom, Netherlands and United States. Yemisi Solanke's co-authors include Fiona S. Lucas, Joanne Wiseman, Ashley P. Hancock, Michael Snowden, Panayiotis A. Procopiou, Wendy R. Irving, Keith Biggadike, Lisa E. Ranshaw, A.J. Harker and Richard Angell and has published in prestigious journals such as Gastroenterology, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Yemisi Solanke

16 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yemisi Solanke United Kingdom 10 184 159 96 77 60 16 472
Ashley P. Hancock United Kingdom 7 79 0.4× 84 0.5× 26 0.3× 77 1.0× 59 1.0× 10 306
Shuzhan Zheng China 13 92 0.5× 225 1.4× 9 0.1× 85 1.1× 12 0.2× 28 466
Ojia Skaff Australia 8 188 1.0× 112 0.7× 53 0.6× 3 0.0× 22 0.4× 8 466
Yuki Kitamura Japan 16 251 1.4× 320 2.0× 19 0.2× 10 0.1× 15 0.3× 59 738
Jason M. Rohde United States 12 312 1.7× 316 2.0× 70 0.7× 3 0.0× 22 0.4× 13 685
Yuefan Wang United States 13 286 1.6× 220 1.4× 32 0.3× 5 0.1× 9 0.1× 34 509
Nikolay V. Lukashev Russia 15 216 1.2× 331 2.1× 19 0.2× 5 0.1× 63 1.1× 40 583
Yang Ke China 12 314 1.7× 171 1.1× 53 0.6× 3 0.0× 4 0.1× 29 616
Hetalben Patel United States 10 270 1.5× 23 0.1× 17 0.2× 7 0.1× 84 1.4× 13 460
K. S. Rangappa India 13 152 0.8× 236 1.5× 23 0.2× 10 0.1× 3 0.1× 38 484

Countries citing papers authored by Yemisi Solanke

Since Specialization
Citations

This map shows the geographic impact of Yemisi Solanke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yemisi Solanke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yemisi Solanke more than expected).

Fields of papers citing papers by Yemisi Solanke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yemisi Solanke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yemisi Solanke. The network helps show where Yemisi Solanke may publish in the future.

Co-authorship network of co-authors of Yemisi Solanke

This figure shows the co-authorship network connecting the top 25 collaborators of Yemisi Solanke. A scholar is included among the top collaborators of Yemisi Solanke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yemisi Solanke. Yemisi Solanke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Rowley, Ann, Ajay Duggal, Yemisi Solanke, et al.. (2018). P359 A novel phase 1 trial design to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics of TOP1288, a narrow spectrum kinase inhibitor, delivered topically to the colon via oral administration. Journal of Crohn s and Colitis. 12(supplement_1). S285–S286. 1 indexed citations
3.
Hagan, Suzanne, Matthew C. T. Fyfe, Katherine Oliver, et al.. (2018). Narrow Spectrum Kinase Inhibitors Demonstrate Promise for the Treatment of Dry Eye Disease and Other Ocular Inflammatory Disorders. Investigative Ophthalmology & Visual Science. 59(3). 1443–1443. 10 indexed citations
4.
Biancheri, Paolo, Matthew C. T. Fyfe, T T MacDonald, et al.. (2017). P032 The pharmacological profile of TOP1288, a narrow spectrum kinase inhibitor in clinical development as an anti-inflammatory treatment for ulcerative colitis. Journal of Crohn s and Colitis. 11(suppl_1). S95–S95. 1 indexed citations
5.
6.
Duggal, Ajay, Adele Rowley, Meika Foster, et al.. (2017). P684 A first clinical trial of a novel narrow spectrum kinase inhibitor TOP1288 in patients with ulcerative colitis. Journal of Crohn s and Colitis. 11(suppl_1). S429–S430. 1 indexed citations
7.
Biancheri, Paolo, Matthew C. T. Fyfe, Thomas T. MacDonald, et al.. (2016). Effect of Narrow Spectrum Versus Selective Kinase Inhibitors on the Intestinal Proinflammatory Immune Response in Ulcerative Colitis. Inflammatory Bowel Diseases. 22(6). 1306–1315. 6 indexed citations
8.
Tralau-Stewart, Cathy, Richard A. Williamson, Anthony T. Nials, et al.. (2011). GSK256066, an Exceptionally High-Affinity and Selective Inhibitor of Phosphodiesterase 4 Suitable for Administration by Inhalation: In Vitro, Kinetic, and In Vivo Characterization. Journal of Pharmacology and Experimental Therapeutics. 337(1). 145–154. 51 indexed citations
9.
Mitchell, Charlotte, Stuart P. Ballantine, Diane M. Coe, et al.. (2010). Pyrazolopyridines as potent PDE4B inhibitors: 5-Heterocycle SAR. Bioorganic & Medicinal Chemistry Letters. 20(19). 5803–5806. 34 indexed citations
10.
Down, Kenneth, Paul Bamborough, Catherine M. Alder, et al.. (2010). The discovery and initial optimisation of pyrrole-2-carboxamides as inhibitors of p38α MAP kinase. Bioorganic & Medicinal Chemistry Letters. 20(13). 3936–3940. 10 indexed citations
11.
Woodrow, Michael D., Stuart P. Ballantine, Michael D. Barker, et al.. (2009). Quinolines as a novel structural class of potent and selective PDE4 inhibitors: Optimisation for oral administration. Bioorganic & Medicinal Chemistry Letters. 19(5). 1380–1385. 54 indexed citations
12.
13.
Christopher, J.A., Paul Bamborough, Catherine M. Alder, et al.. (2009). Discovery of 6-Aryl-7-alkoxyisoquinoline Inhibitors of IκB Kinase-β (IKK-β). Journal of Medicinal Chemistry. 52(9). 3098–3102. 29 indexed citations
14.
Hamblin, J., Stuart P. Ballantine, Anthony W. J. Cooper, et al.. (2008). Pyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(14). 4237–4241. 59 indexed citations
15.
Procopiou, Panayiotis A., Keith Biggadike, Ashley P. Hancock, et al.. (2001). Novel Glucocorticoid Antedrugs Possessing a 17β-(γ-Lactone) Ring. Journal of Medicinal Chemistry. 44(4). 602–612. 38 indexed citations
16.
Biggadike, Keith, Richard Angell, Ashley P. Hancock, et al.. (1999). Selective Plasma Hydrolysis of Glucocorticoid γ-Lactones and Cyclic Carbonates by the Enzyme Paraoxonase: An Ideal Plasma Inactivation Mechanism. Journal of Medicinal Chemistry. 43(1). 19–21. 157 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ashley P. Hancock Breakdown of academic impact, for papers by Shuzhan Zheng Breakdown of academic impact, for papers by Ojia Skaff Breakdown of academic impact, for papers by Yuki Kitamura Breakdown of academic impact, for papers by Jason M. Rohde Breakdown of academic impact, for papers by Yuefan Wang Breakdown of academic impact, for papers by Nikolay V. Lukashev Breakdown of academic impact, for papers by Yang Ke Breakdown of academic impact, for papers by Hetalben Patel Breakdown of academic impact, for papers by K. S. Rangappa
Rankless by CCL
2026